Glassia Disease Interactions
There is 1 disease interaction with Glassia (alpha 1-proteinase inhibitor).
Alpha 1- proteinase inhibitor
Major Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The use of alpha 1- proteinase inhibitor is contraindicated in immunoglobulin A (IgA) deficient patients with antibodies against IgA, due to the risk of severe hypersensitivity.
Switch to professional interaction data
Report options
More about Glassia (alpha 1-proteinase inhibitor)
- Glassia consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous respiratory agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Prolastin-C
Prolastin-C is used for alpha-1 proteinase inhibitor deficiency
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Prolastin
Prolastin-C Liquid may be used to replace missing alpha1-proteinase inhibitor (alpha1-PI) levels in ...
Zemaira
Zemaira is used to treat alpha 1-antitrypsin deficiency in people who have symptoms of emphysema ...
Aralast NP
Aralast NP is used for alpha-1 proteinase inhibitor deficiency
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.